-transparent.png){kind=logo}
The authors discuss the potent antiarrhythmic drug amiodarone, with emphasis on indications, efficacy and side effects. At present the drug can be prescribed only by specialists in internal medicine. In order to monitor the efficacy of the drug and any side effects the patient should preferably be evaluated every three to six months. Use of intravenous amiodarone in hospital is effective in many cases but, so far, documentation on this treatment is limited.
Related Publications
K Gjesdal, and
J P Amlie, and
O M Orning
September 1985,
La Clinica terapeutica,
K Gjesdal, and
J P Amlie, and
O M Orning
April 1986,
Ugeskrift for laeger,
K Gjesdal, and
J P Amlie, and
O M Orning
November 1985,
Clinical science (London, England : 1979),
K Gjesdal, and
J P Amlie, and
O M Orning
January 2009,
Vestnik Rossiiskoi akademii meditsinskikh nauk,
K Gjesdal, and
J P Amlie, and
O M Orning
December 1981,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Gjesdal, and
J P Amlie, and
O M Orning
April 2013,
Cardiovascular drugs and therapy,
K Gjesdal, and
J P Amlie, and
O M Orning
May 1990,
Kardiologiia,
K Gjesdal, and
J P Amlie, and
O M Orning
February 1971,
Bruxelles medical,
K Gjesdal, and
J P Amlie, and
O M Orning
January 1981,
Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
K Gjesdal, and
J P Amlie, and
O M Orning
January 1981,
Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
